BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10222689)

  • 1. [Anticholesteremic statins reduce myocardial infarction. Milestone studies give a straight answer--at least concerning the males].
    Carlson LA
    Lakartidningen; 1999 Apr; 96(14):1725-8. PubMed ID: 10222689
    [No Abstract]   [Full Text] [Related]  

  • 2. [Statins in practice of the vascular surgeon and cardiologist].
    Pokrovskiĭ AV; Suntsov DS
    Angiol Sosud Khir; 2009; 15(2):123-7. PubMed ID: 19806952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ezetimib--the first selective cholesterol resorption inhibitors. Strengthening of statins].
    MMW Fortschr Med; 2002 Nov; 144(48):52-3. PubMed ID: 12532546
    [No Abstract]   [Full Text] [Related]  

  • 4. Statins indispensable for people with diabetes.
    Health News; 2003 Aug; 9(8):6. PubMed ID: 12971317
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lowering of LDL cholesterol prevents cardiovascular diseases. "Normal values" are too high--treatment time is a crucial factor].
    Rudling M
    Lakartidningen; 2006 Oct 25-31; 103(43):3278-82. PubMed ID: 17117659
    [No Abstract]   [Full Text] [Related]  

  • 6. [Incidence variations of myocardial infarction].
    Westlund K
    Nord Med; 1971 Apr; 85(15):458-65. PubMed ID: 5574983
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of statins following myocardial infarction before and after the 4S study].
    Krefting E; Hansen JB; Nordøy A
    Tidsskr Nor Laegeforen; 1999 Aug; 119(20):2986-9. PubMed ID: 10504844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Myocardial infarct--is prevention possible?].
    Nicolaysen R
    Nord Med; 1971 Apr; 85(15):472-4. PubMed ID: 5574986
    [No Abstract]   [Full Text] [Related]  

  • 9. Rationale for use of lipid-lowering drugs.
    Dayton S
    Fed Proc; 1971; 30(3):849-56. PubMed ID: 5575297
    [No Abstract]   [Full Text] [Related]  

  • 10. Statins and cardiovascular disease--major therapeutic advances but are we seizing the moment?
    Mulcahy D
    Eur Heart J; 2001 Jul; 22(13):1065-6. PubMed ID: 11428844
    [No Abstract]   [Full Text] [Related]  

  • 11. [What the MONICA project has taught us about cardiovascular diseases--society, public health and health care].
    Asplund K; Eliasson M; Janlert U; Stegmayr B
    Lakartidningen; 2006 Oct 4-10; 103(40):3006-11. PubMed ID: 17115672
    [No Abstract]   [Full Text] [Related]  

  • 12. [The TNT debate gives a lift to the debate about high-dose statins. Lower LDL cholesterol levels further reduce the cardiovascular risk].
    Olsson AG
    Lakartidningen; 2005 May 2-15; 102(18-19):1393-4. PubMed ID: 15929421
    [No Abstract]   [Full Text] [Related]  

  • 13. Study suggests statins for diabetics with healthy LDL cholesterol levels.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Sep; 15(18):1-2, 6-7. PubMed ID: 15452942
    [No Abstract]   [Full Text] [Related]  

  • 14. [Type 2 diabetics are high risk patients. Concerning LDL-cholesterol to approach effectively to two sources].
    MMW Fortschr Med; 2005 Nov; 147(44):52-3. PubMed ID: 16302495
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cholesterol lowering--Quo vadis? WOS (West of Scotland)--study of pravastin--a milestone in the prevention of myocardial infarct?!].
    Fortschr Med Suppl; 1995; 170():1-7. PubMed ID: 9022407
    [No Abstract]   [Full Text] [Related]  

  • 16. Factors associated with recurrent coronary events among patients with cardiovascular disease.
    McConnell KJ; Olson KL; Delate T; Merenich JA;
    Pharmacotherapy; 2009 Aug; 29(8):906-13. PubMed ID: 19637943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment with statins: further data from the Heart Protection Study].
    Tonstad S; Holme I
    Tidsskr Nor Laegeforen; 2002 Nov; 122(29):2777-80. PubMed ID: 12523144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [When will fibrinogen screening become available?].
    Ernst E
    Dtsch Med Wochenschr; 1991 Dec; 116(49):1888-9. PubMed ID: 1743100
    [No Abstract]   [Full Text] [Related]  

  • 19. [The community as a basis for prevention].
    Nüssel E; Buchholz L; Ebschner KJ; Bergdolt H; Morgenstern W
    Internist (Berl); 1980 Aug; 21(8):437-45. PubMed ID: 7002853
    [No Abstract]   [Full Text] [Related]  

  • 20. [Total cardiovascular risk. When is a medication prophylaxis meaningful].
    Einecke D
    MMW Fortschr Med; 2003 Oct; 145(44):6-8. PubMed ID: 14655495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.